DeNovaMed
OverviewSuggest Edit
DeNovaMed is a pharmaceutical company specializing in therapeutic approaches to combat bacterial infections. It develops a Gram negative and Gram positive program focused on oral/iv delivery of antibiotics to allow lower, less toxic doses of colistin. The Gram positive program also aims to develop a topical antibiotic for treating diabetic foot infections.
| Type | Private | |
| Founded | 2006 | |
| HQ | Halifax, CA | Map |
| Website | denovamed.com |
Locations
Latest Updates
| Employees (est.) (May 2020) | 6 | |
| Cybersecurity rating | B | More |
Key People/Management at DeNovaMed
Christopher R. McMaster
President and CEO
Donald Weaver
Chief Medical Officer
Z. Sam Ruttonsha
Board Director
DeNovaMed Office Locations
DeNovaMed has an office in Halifax
Halifax, CA (HQ)
5849 University Ave
DeNovaMed Financials and Metrics
Summary Metrics
Founding Date | 2006 |
DeNovaMed latest funding size | $500 k |
DeNovaMed Cybersecurity Score
DeNovaMed Online and Social Media Presence
DeNovaMed's Trends
DeNovaMed Frequently Asked Questions
When was DeNovaMed founded?
DeNovaMed was founded in 2006.
Who are DeNovaMed key executives?
DeNovaMed's key executives are Christopher R. McMaster, Donald Weaver and Z. Sam Ruttonsha.
How many employees does DeNovaMed have?
DeNovaMed has 6 employees.
Who are DeNovaMed competitors?
Competitors of DeNovaMed include Corestem, Tikomed and Sanofi.
Where is DeNovaMed headquarters?
DeNovaMed headquarters is located at 5849 University Ave, Halifax.
Where are DeNovaMed offices?
DeNovaMed has an office in Halifax.
How many offices does DeNovaMed have?
DeNovaMed has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies